Overview

Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This study is conducted in the United States of America (USA). The aim of this study is to investigate the at-home-administration of bypassing agents for treatment of bleeding episodes in patients with congenital haemophilia with inhibitors to factors VIII and IX. We are further investigating how bleeding episodes affect the quality of life of the patient and their family or caregivers.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Anti-inhibitor coagulant complex